Newmarket Corp: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on Apr 23, 2026 and accepted by EDGAR at Apr 23, 2026, 08:53 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-01-01 to 2026-03-31 | $669.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-01-01 to 2026-03-31 | $448.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2026-01-01 to 2026-03-31 | $220.9m | us-gaap:GrossProfit |
| Research and development | 3 months2026-01-01 to 2026-03-31 | $31.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2026-01-01 to 2026-03-31 | $46.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-01-01 to 2026-03-31 | $143.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-01-01 to 2026-03-31 | $8.8m | us-gaap:InterestExpense |
| Income tax | 3 months2026-01-01 to 2026-03-31 | $33.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | $118.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | $12.62 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | $12.62 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 9,321,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2026-01-01 to 2026-03-31 | $124.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2026-01-01 to 2026-03-31 | $24.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2026-01-01 to 2026-03-31 | $28.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2026-01-01 to 2026-03-31 | $125.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-03-31 | $73.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-03-31 | $1.06bn | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $3.50bn | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $417.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $1.77bn | us-gaap:Liabilities |
| Long-term debt | At period end2026-03-31 | $939.6m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2026-03-31 | $1.73bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2026-03-31 | 9,198,019 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001282637-26-000009. Last ingested by Listed: Oct 29, 2026, 19:40 ET. Listed shows no prices and gives no investment advice.